Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Apr / Within Spitting Distance
Companion diagnostics

Within Spitting Distance

Could saliva sampling be the key to fast, affordable, and accurate breast cancer screening?

By Jessica Allerton 04/24/2024 News 1 min read

Share

Thanks to technological advancements and collaborative research, a hand-held biosensor has been created for the detection of cancer biomarkers in saliva samples (1).

With 2.3 million women diagnosed and 685,000 deaths globally in 2020 (2), breast cancer remains a major concern across the world. And that’s why researchers from the University of Florida and National Yang Ming Chiao Tung University in Taiwan joined forces to create a noninvasive and accessible means of identifying breast cancer.

Using commercially available strips akin to those used in glucose testing and a handheld printed circuit board (PCB), researchers created a handheld biosensor for portable testing. Each strip is functionalized with antibodies specific to cancer biomarkers HER2 and CA15-3. The team demonstrated limits of detection as low as 1 fg/ml – and with as little as 3 μL of saliva.

“Our breast cancer screening method offers affordability, speed, minimal saliva requirement, and high accuracy,” says lead author Hsiao-Hsuan Wan, “This breakthrough is particularly useful in resource-limited regions that cannot access advanced technologies, such as MRI.”

But the researchers aren’t quitting while they’re ahead; Wan expresses excitement for the future, “We’re currently in the process of developing a tablet-controlled version of the PCB, allowing us to store data in the cloud, simplify data transfer, and enable efficient access to patient information. This holds promise for medical professionals globally – providing swift, simple, and successful point-of-service screening.”

Looking further ahead, Wan and colleagues have set their sights on other health conditions, using a similar approach to develop a screening test for oral cancer and expanding into infectious diseases, such as Lyme disease and foot and mouth disease.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. H Wan et al., J Vac Sci Technol B Nanotechnol Microelectron, 42, 2 (2024). PMID:38362284
  2. World Health Organization (2023). Available at: https://bitly.ws/vzCR

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Inside Industry
Companion diagnostics
Inside Industry

November 17, 2016

1 min read

The pathologist’s perspective on developing a companion diagnostic

Collaborating Early to Advance Precision Medicine
Companion diagnostics
Collaborating Early to Advance Precision Medicine

August 2, 2022

7 min read

A look inside Thermo Fisher’s CDx program with Garret Hampton

Closer Coordination, Better Outcomes
Companion diagnostics
Closer Coordination, Better Outcomes

May 29, 2023

6 min read

How the pathology-oncology care team can work together more closely to leverage the true power of precision therapies

The Story Continues To Be Written
Companion diagnostics
The Story Continues To Be Written

December 5, 2023

5 min read

The ever-developing tale of companion diagnostic tests in precision oncology

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.